Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brent S Kendrick

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Pharmaceutical Sciences|November 3, 2019
Professors John F. Carpenter and Theodore W. Randolph: 2 Giants With a Special Synergy in the Field of Biopharmaceutical Science and EngineeringBrent S Kendrick, Eva Y Chi
Journal of Pharmaceutical Sciences|August 24, 2023
Correcting Ultraviolet-Visible Spectra for Baseline ArtifactsAndrew J Basalla, Brent S Kendrick
Biotechnology Progress|April 12, 2007
Protein misfolding and aggregationRegina M Murphy, Brent S Kendrick
Pharmaceutical Biotechnology|May 4, 2002
Physical stabilization of proteins in aqueous solutionBrent S Kendrick, Tiansheng Li, Byeong S Chang
Methods in Enzymology|September 29, 2015
Guidance to Achieve Accurate Aggregate Quantitation in Biopharmaceuticals by SV-AUCKelly K Arthur, Brent S Kendrick, John P Gabrielson
Journal of Pharmaceutical Sciences|May 30, 2020
Universal Qualification of Analytical Procedures for Characterization and Control of BiologicsJohn P Gabrielson, Brent S Kendrick, Jared A Young
Journal of Pharmaceutical Sciences|May 16, 2025
Analytical control strategy for biologics. Part II: Roadmap for development and implementationKrishnan Sampathkumar, Brent S Kendrick, John P Gabrielson, et al.
Journal of Pharmaceutical Sciences|May 12, 2025
Analytical control strategy for biologics. Part I: FoundationsBrent S Kendrick, Krishnan Sampathkumar, John P Gabrielson, et al.
Analytical Biochemistry|April 9, 2008
Measurement of the second osmotic virial coefficient for protein solutions exhibiting monomer-dimer equilibriumJohn R Alford, Brent S Kendrick, John F Carpenter, et al.
Journal of Pharmaceutical Sciences|October 10, 2007
High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kineticsJohn R Alford, Brent S Kendrick, John F Carpenter, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical Sciences|November 3, 2019
Professors John F. Carpenter and Theodore W. Randolph: 2 Giants With a Special Synergy in the Field of Biopharmaceutical Science and EngineeringBrent S Kendrick, Eva Y Chi
Journal of Pharmaceutical Sciences|August 24, 2023
Correcting Ultraviolet-Visible Spectra for Baseline ArtifactsAndrew J Basalla, Brent S Kendrick
Biotechnology Progress|April 12, 2007
Protein misfolding and aggregationRegina M Murphy, Brent S Kendrick
Pharmaceutical Biotechnology|May 4, 2002
Physical stabilization of proteins in aqueous solutionBrent S Kendrick, Tiansheng Li, Byeong S Chang
Methods in Enzymology|September 29, 2015
Guidance to Achieve Accurate Aggregate Quantitation in Biopharmaceuticals by SV-AUCKelly K Arthur, Brent S Kendrick, John P Gabrielson
Journal of Pharmaceutical Sciences|May 30, 2020
Universal Qualification of Analytical Procedures for Characterization and Control of BiologicsJohn P Gabrielson, Brent S Kendrick, Jared A Young
Journal of Pharmaceutical Sciences|May 16, 2025
Analytical control strategy for biologics. Part II: Roadmap for development and implementationKrishnan Sampathkumar, Brent S Kendrick, John P Gabrielson, et al.
Journal of Pharmaceutical Sciences|May 12, 2025
Analytical control strategy for biologics. Part I: FoundationsBrent S Kendrick, Krishnan Sampathkumar, John P Gabrielson, et al.
Analytical Biochemistry|April 9, 2008
Measurement of the second osmotic virial coefficient for protein solutions exhibiting monomer-dimer equilibriumJohn R Alford, Brent S Kendrick, John F Carpenter, et al.
Journal of Pharmaceutical Sciences|October 10, 2007
High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kineticsJohn R Alford, Brent S Kendrick, John F Carpenter, et al.
Pageof 3